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A HISTORY OF RHEUMATIC FEVER*
GORDON MANSON, M.D.**

'There is perhaps no serious disease more familiar to us than acute articular
rheumatism; it is one of the disorders most commonly seen in the wards of a general
hospital; it is constantly encountered in private practice; and I must confess that when
I chose rheumatism as the subject of the lectures you have done me the honour to
ask me to deliver, I was almost afraid that it might be deemed too trite and
commonplace, destitute of sufficient novelty and interest. But there is a certain
advantage in treating of a matter with which the audience are familiar, and I trust
I shall be able to present it to you in some new aspects, and to attract attention to
certain points of great interest hitherto, I think, insufficiently considered, and thus
I hope that my choice may be justified, and any unfavourable criticism in this aspect
eventually disarmed".
I regret to say that this introduction is not original with your speaker but
rather is the introduction of Dr. W. B. Cheadle to his Harveian lectures for the
year 18891 These lectures by Dr. Cheadle are of particular significance in the
history of the development of our thinking regarding rheumatic fever and we shall
speak more of them later. Suffice it to say, however. Dr. Cheadle's introduction is
a fitting prologue to our consideration this evening of the evolution of our concept
of the rheumatic state.
The word rheumatism, of course, derives from the Greek 'pew and refers to
the flowing of humors into the joints of affected persons. Rheumatism is a disease
well known to medical antiquity and one of the earliest historical accounts we have
of the condition is aUributed by Guillaume Baillou^ in 1616 to Hippocrates whom
he quotes as follows: "In those in whom pains and swellings come and go around
the joints, and these not after the manner of gout in the foot, one will find large
viscera and in the urine, a white sediment . . . Now this disease occurs in those in
childhood and youth who were wont to have nose-bleeding but have since lost it".
In the second century after Christ that astute clinical observer Aretaeus' noted — "In
many cases the gout has passed into dropsy and sometimes into asthma, and from
this succession there is no escape". Here he refers to those unfortunate rheumatics
with chronic heart disease and congestive failure before the days of the fox-glove.
We should remember that early physicians did not differentiate clearly between what
today we know as rheumatism and gout. Aretaeus' clinical acumen is not confined
to rheumatism for we had the opportunity last year of hearing from Fred WhitehousC
of his contributions to our knowledge of diabetes. We should also remember that he
was the first to describe the flaring of the ala nasi and expiratory grunt seen in the
lobar pneumonia patient. Finally to Aretaeus belongs the credit of being the first
to note the great importance of a positive family history in the diagnosis of the acute
rheumatic state. Some 1700 years have elapsed since his contributions and we are
*Presented before a meeting of the Henry Ford Hospital "2.11 Club" on May 4, 1959.
*'-Department of Pediatrics.
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still faced with the problem of trying to prevail on house officers and staff physicians
to take an adequate family history from the acute rheumatic fever patient. About
the same time Celsus' noted that, " . . . children in whom there has been nosebleeding, which has ceased are sure to be troubled by pains in the head, or they
have some severe joint ulcerations, or they also become debilitated by disease".
Not much is found in the medical literature from the second or third century
until the observations of Guillaume Baillou in 1616. Baillou is remembered chiefly
for his original description of pertussis in 1578' but in 1616 made the following
significant observations about the two principal clinical types of rheumatic fever:
"Two kinds of persons experience teaches are attacked especially by this affection —
one of them healthy seen in the fullness of health but soon attacked by the disease;
when now this disease attacks, a spontaneous lassitude precedes it and the blood
is diseased, and indeed this is found to be the case, as was noted by Hippocrates —
they are obviously sick as soon as they are attacked. The other kind of persons usually
attacked by this affection are those who at the time are really sick, indeed especially
with a chronic disease, which has now desisted or seems dissolved by a false and
hasty crisis, but however it survives and is not destroyed — the case of Pres. Greyotte
demonstrates this, whom this type of disease attacked most severely".' Thus we
see that in the early 17th century it was appreciated that rheumatic fever might
present not only as a severe acute illness but also be seen as a subtle, insidious, low
grade inflammatory process eventuating in the type of patient whom we occasionally
see in the height of young adulthood with a tight mitral stenosis in the absence of a
history of acute rheumatic fever.
Thomas Sydenham' was apparently the first to note that acute rheumatic fever
usually follows an acute respiratory infection. He wrote: "The sad list of symptoms
begins with chills and shivers; these are followed immediately by heat, disquietude,
thirst, and the other concomitants of fever. One or two days after this (sometimes
sooner) the patient is attacked by severe pains in the joints, sometimes in one and
sometimes in another, sometimes in his wrists, sometimes in his shoulder, sometimes
in the knee — in this last joint oftenest. The pain changes its place from time to
time, takes the joints in turn, and affects the one that it attacks last with redness and
swelling. Sometimes during the first days, the fever and the above named symptoms
go hand in hand; the fever, however, gradually goes off whilst the pain only remains;
sometimes, however, it grows worse. The febrile matter has, in that case, been
transferred to the joints".
In 1686 Sydenham described the chorea minor which bears his name but did
not associate it with the rheumatic state. The popular eponym, St. Vitus' dance,
applied to this manifestation, interestingly, derives its name from a fancied resemblance of patients so afflicted to a dancing mania seen amongst young people
smitten with religious fervor in the early 15th century in the Strasbourg area of
Alsace. History records that the chief magistrate of that community ordered those
persons so affected to St. Vitus' chapel in Zabern in Alsace.' Today we note with
interest that our patients may know what St. Vitus' Dance is and yet have no
knowledge of the word "chorea" when we take our clinical histories.
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Scarlet fever, which later came to be associated etiologically with the onset of
acute rheumatic fever, was described by Daniel Sennert (1572-1637) of Breslau,
Germany. Major' states that the existence of the disease as a clinical entity was
probably suggested to Sennert by his brother-in-law Doring. Sennert was a conscientious and devoted physician. Six times epidemics of plague invaded his city
and because of fear of the disease, most of the physicians in the city fled. Sennert
was one of the few who invariably remained to care for his people and as a consequence died of plague when the 7th epidemic raged through his community. It
remained however for Sydenham to clearly differentiate the clinical courses of
scarlet fever and measles which had hitherto been confused. According to Lettsom,'"
Sydenham died a "martyr to the gout". In the way of therapy Sydenham is remembered
for his emphasis on the clinical uses of quinine though he did not make particular
reference to the use of this drug in the rheumatic state. 200 years were to elapse
before the clinical usefulness of antipyretics in the rheumatic state would be appreciated.
With the rise of pathologic anatomy in the early 18th century, inevitably
descriptions of rheumatic lesions began to appear. Valvular vegetations were first
noted by Lancisi," a papal physician in the year 1709 who published autopsy findings.
Similar findings were later pubUshed in 1761 by Morgagni." A year previously Anton
Storck" of Vienna, a pharmacologist and student of the famous pathologist Boerhaave,
described the autopsy findings of pleural and pulmonary lesions in acute rheumatic
fever. In 1761 Richard Pulteney" an English pharmacist, provided an excellent
description of rheumatic heart disease at autopsy without recognizing the nature of
the disease. In the latter part of the 18th century, various clinical and pathological
observations began to be correlated which served to relate the acute rheumatic state
as seen clinically with organic heart disease seen at autopsy. In 1776 William Cullen,"
Professor of Pharmacology in Edinburgh, pointed out that rheumatic joints never suppurated. Lettsom," a biographer of Sydenham, reported what appears to have been
the thrill of mitral stenosis in the following graphic terms: "Upon laying the hand
on the sternum, it gave a sensation to the touch — somewhat like a fluid passing
through a cylinder, in the central substance of which a ball had been infixed, against
which the impulse of the circulating fluid had been directed, and by it repelled with
a vibratory motion along the cylinder".
Edward Jenner" in July 29, 1789 addressed the Fleece Medical Society on a
disease of the heart following acute rheumatism, illustrated with dissections. This
paper was never pubUshed and has apparently been lost. One finds no reference to its
content in the literature. Our only knowledge of its existence comes from the fact
that in 1805 Jenner wrote to a Dr. Parry regarding a friend's death and in this letter
referred to the paper and requested its return. So far as is known the paper was
never returned. Matthew Baillie, whose text on Morbid Anatomy'" contained some
of the finest pathological plates printed up until that time, in 1797 stated in his
text, "the causes which produce a morbid growth of the heart are probably not all of
them ascertained. The chief causes are ossification or thickening of some of its valves.
On some occasions the heart will become enlarged from rheumatism attacking it".
Baillie appended a footnote to this observation as follows, "Dr. Pitcairn observed this
147

Manson
in several cases and is to be considered as the first person who made this important
observation". (The observation was made in 1788 by Pitcairn). The career of Matthew
Baillie as a physician and pathologist deserves further comment. He was the last of
a quartet of famous English physicians immortalized in "The Gold Headed Cane".
These men — Mead, Askew, Pitcairn and Baillie were successive owners of the Gold
Headed Cane signifying professional leadership in 18th century and early 19th century
London. When Baillie died, his widow presented the Gold Headed Cane to the
Royal College of Physicians in whose museum it still resides as a tribute to the
medical acumen of these great clinicians.'
John Haygarth" in 1805 made the significant observation that acute rheumatic
fever is not always accompanied by fever and stated; "The term rheumatism, both
in common and medical languages includes a great variety of disorders, which ought
to be distinguished from each other by different names. After separating it from the
nodosity of the joints, tic douloreux, sciatica, lumbago, and other diseases which the
nosologists have placed under this classification, there still remain 470 cases of
rheumatism. This disease is generally classed with fevers, and yet only 170 (about
one-third of them) had any fever". With this introduction, Haygarth then discusses
the clinical description and course of the disease. He was among the first to find
Peruvian Bark excellent in the management of rheumatic fever though Sydenham
had earlier appreciated its symptomtic effects in a variety of disease states.
The early 19th century was punctuated by a variety of climatological and epidemiological observations, largely speculative in character. In this period we also see
contributions regarding various manifestations of the rheumatic state. In 1810 William
Wells' described rheumatic nodules. Wells' background was interesting from an
historical point of view. He was born in Charleston, South Carolina of staunchly
Loyalist parents and as a child his father dressed him in a blue coat lest he be
mistaken for an American. His education was largely English and in his younger
days he made a number of contributions as a physicist and his "Essay on Dew" was
read before the Royal Society in 1814. A year earlier he had proposed a theory of
natural selection which antedated by some 40 years the publication of the "Origin
of Species" by Charles Darwin. This priority of Wells was acknowledged by Darwin
in his classic volume. In describing rheumatic nodules in regard to a 15 year old
girl he states: "many of the tendons of the superficial muscles of this patient were
studded with numerous small hard tumors, an appearance which I have observed only
in one other person, a thin and feeble man forty-one years old, who also labored
under rheumatism".
The association of rheumatism and chorea is attributed to Thomas Addison of
Guy's Hospital, by Babbington to whom we are indebted for the development of
laryngoscopy." The importance of myocarditis and its preponderance in the pediatric
age group was noted by Robert Adams"' of the Jervis Street Hospital, Dublin, in 1827.
It was later re-emphasized by Sturges^' in 1876 whose name is perpetuated in the
Kalischer-Sturges-Weber-Dmitri Syndrome, to give it its full and historical appellation.
Another Guy's Hospital physician, Richard Bright" in 1831 described what he termed
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roseola annulata as a manifestation of the rheumatic state, and in 1835 Thomas
Watson" stated: " I confidently believe the to and fro sound to be always indicative
of inflammation of the external membrane . . . the blowing sound to be always
indicative of inflammation of the internal membrane of the heart". We might today
take issue with Watson regarding the interpretation of abnormal heart sounds but
we must acknowledge his important observation regarding the age distribution of the
cardiac and arthritic manifestations of the rheumatic state which he expressed as
follows: "One law respecting the connection between the cardiac and the arthritic
symptoms may be stated with confidence, namely, that the younger the patient who
suffers acute rheumatism (and I have seen it as early as the third or fourth year)
the more likely will he be to have rheumatic carditis. The chance of this combination
appears to diminish after puberty as life advances". Interestingly enough, we probably
owe the term "Waterhammer Pulse" to Watson rather than to Corrigan since
Corrigan, in his description of the collapsing pulse of aortic insufficiency, does not
use the term Waterhammer Pulse."
During the 18th century various theories were proposed regarding the pathogenesis of the rheumatic state. One of the earliest was suggested by Baron Corvisart'''
who was Napoleon's physician. It was the Baron's suggestion that rheumatic valvular
vegetations were internal manifestations of venereal warts. Whether this is a serious
hypothesis or is a consequence of the inclinations and habits of the French army is
open to conjecture. In 1827 William Prout," an English chemist, found elevation
of blood lactic acid and suggested that a disturbance in this metabolite was responsible
for the rheumatic state. His methods are not available to us and it is interseting
to consider what accounted for the increase in blood lactic acid he observed. It is
entirely possible that it may have been due to congestive failure which has been observed
to produce an increase in blood lactic acid level in terminal patients following unsuccessful cardiotomy. It may also have been due to unrecognized cases of Pompe's
disease. During the middle 18th century the idea that the rheumatic state was a
consequence of an increased blood uric acid level was popular until A. E. Garrod"
demonstrated that the uric acid level was normal in acute rheumatic fever patients.
Garrod later distinguished himself by giving us the concept of inborn errors of
metabolism. In 1861 Armand Trousseau," who is known for the sign of tetany which
bears his name, pointed out the temporal relationships of rheumatic angina (i.e.
tonsillitis) to subsequent acute rheumatism.
The major contribution, and indeed our modern concept of the rheumatic state,
was proposed by W. B. Cheadle in the Harveian lectures for the year 1889.' Dr.
Cheadle himself was a remarkable individual.^' He was the co-author of a book on
explorations in the Canadian Rocky Mountains which he undertook before embarking
upon his medical career. His explorations took place in the 1860's at a time when
travelers in the area stood a good chance of having their scalps lifted by any of the
several techniques described to us a couple of years ago so capably by our late
colleague. Dr. Robert Clifford.^' Cheadle's interests and original work lay in the area
of measles, infant feeding, heart disease, cirrhosis. Grave's Disease and he was one
of the first to separate infantile rickets and scurvy. He had a deep personal interest
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in the rheumatic state for his appreciation of the importance of family history was
heightened by the fact that his wife and son suffered from rheumatic fever. Oddly
enough he made no original contributions to our knowlegde of the rheumatic state
but in the matter of a very few years became known throughout the world as an expert
on rheumatism as a consequence of his Harveian lectures. This was further insured
by his authorship of the section on rheumatic fever in Keating's "Cyclopedia of
Diseases of Children," published in Philadelphia in 1890 which was the standard
American pediatric text of the day. Cheadle took the various divergent manifestations
of the rheumatic state and put them together for us in a neat pathogenetic package
which has remained unchanged to the present time. He appreciated the fact that the
manifestations in childhood differ from those in adulthood and that childhood manifestations are followed by adult manifestations as the individual grows older. American
and British pediatricians in the early part of the present century all learned what was
termed "Cheadle's Cycle" consisting of: endocarditis, pericarditis, pleurisy, exudative
erythema, chorea, nodules and tonsillitis. He recognized the predilection of the disease
for connective tissue and pointed out that usually two or three phases occurred together.
The major and minor criteria proposed by the late T. Duckett Jones" do not differ
from this concept. He found that the disease had a familial tendency as strong as
gout and remarked that our appreciation of this, "varies according to the minuteness
of the inquiry made". His discussion of chorea is illuminating to the pediatrician
today. He shrewdly noted that the transient nature of other rheumatic manifestations
in the chorea patient are often evanescent enough to be easily missed and hence
chorea is thought to be of non-rheumatic origin. He reminds us that Roger, whose
name is not unknown to us, pointed out that chorea usually preceded the later development of arthritis and he states in conclusion that, " I do not think the evidence warrants
the assumption that chorea is inevitably of rheumatic origin . . . but I am convinced
that rheumatism is the most common and potent factor". I do not believe that the
question of the etiology and pathogenesis of chorea has progressed much since.
Cheadle clearly differentiated clinically between innocent and organic murmurs and
laments the impossibility of obtaining adequate data on rheumatic patients for statistical
analysis. Here he finds himself in company with Thomas Barlow to whom we owe
our knowledge of the pathogenesis of infantile scurvy. That cardiac hypertrophy
and dilatation without valvular disease can occur in the acute rheumatic fever, Cheadle
pointed out, was recognized in 1881. He noted that Henoch's "Diseases of Children"
in 1883 stated that post scarletinal endocarditis and pericarditis may be of either
rheumatic or uremic origin and hence we see two important manifestations of streptococcosis may both lead to carditis but by entirely different means.
Cheadle lived in a remarkable period in pediatric history. He was contemporary
with Barlow known for his work in scurvy, Garrod who gave us the concept of inborn
errors of metabolism, Thomson whose contribution to the care of the brain damaged
child represented a new concept in the understanding of these children and with
Still whose disease bears his name today." Cheadle's differential diagnosis of the
child who presents with acute arthritis is interesting when compared with a similar
differential diagnosis published in 1958 by a rheumatism center in England:^"
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The Rheumatism Research Unit
Taplow, 1958, 196 patients
1

Cheadle's Differential Diagnosis
a. Leutic epiphysitis
b. Scurvy
c. Rickets
d. Tetany
e. Hemophilia
f. Tuberculosis
g. Pyarthrosis

0
2 (blood dyscrasias)
2 (pulmonary only)
10

The differences in the above disease distribution represent some 70 years of
Pediatric progress. The virtual disappearance of Lues is a tribute to prenatal blood
testing and the efficacy of Fleming's penicillin. The complete disappearance of the
nutritional diseases, scurvy, rickets and tetany are a clear reflection of improved infant
feeding. In the field of two of these nutritional disorders Cheadle himself made original
contributions together with Barlow. Blood dyscrasias remains with us as always.
Tuberculosis is still seen in a small but significant number of cases, more frequently
today in England than in the United States. It might be remembered in passing that
in the United States we have never as a nation embraced BCG vaccination. Finally,
pyarthroses remain with us and the causative organisms remain much as they were in
Cheadle's time, despite current concern over the ubiquitous staphylococcus.
Some six years after Cheadle's remarkable Harveian lectures, the first epidemiological study of the disease was summarized in the Milroy Lectures by Sir Arthur
Newsholme" in the year 1895. These are published in Lancet for the same year. His
data was the result of a cooperative study and a number of important conclusions
were reached regarding the epidemiology of rheumatic fever. Essentially the same
tendencies were found by Coburn in the 20th century. Newsholme showed that the
disease was one affecting individuals in temperate climates. It was shown that the
affected individuals had an inherited predisposition to their disease thereby confirming
the observations of Aretaeus in the second century. Frequently stress, in the form
of fatigue, chill or injury precipitated acute rheumatic activity, foreshadowing by some
40 years, the observations of Selye. Certain years were observed in which there
appeared to be epidemics of acute rheumatic fever usually following a sore throat.
These observations were later confirmed, of course, during World War I I in the
armed forces. Then tendency of acute rheumatic fever to recur was well established
by Newsholme. He concluded that the disease was probably caused by an organism
of low infectivity which tended to be concentrated about the joints and was probably
a saprophytic organism which could on occasion become parasitic. This latter conclusion represents the one false note in these Milroy lectures on rheumatic fever in
the light of our knowledge of the disease today. It was not until the second decade
of the 20th century that the concept of hypersensitivity was suggested as a mechanism
of pathogenesis. Nine years after Newsholme gave the Milroy lectures, Ludwig
AschofP in 1904 reported the histologic characteristics of the lesion we have come
to associate as the essential criterion of acute rheumatic activity, the Aschoff Body.
His description of this important lesion is quoted at length since it is found that our
current textbooks of pathology suffer by comparison:
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"We find peculiar nodules, which appear to be specific to rheumatic myocarditis.
These regularly occur in the neighborhood of small or medium sized vessels and most
frequently in the vicinity of the adventitia, or there existed simultaneously a disease
of aU of the vascular layers, such as is described in arteritis nodosa. The nodules
are unusually small, mostly submihary, and originate by the conglomeration of large
elements, with one or more abnormally large indented polymorphic nuclei. Arrangement of the cells frequently occur in the form of a fan or rosette. The periphery is
formed by the large nucleus, the center by the paler, necrotic mass of confluent cell
protoplasm . . . small and large lymphocytes and polymorphonuclear leukocytes
force themselves a short distance between the large cells of the periphery or form
a peripheral zone, and irregular projections from these may extend far into the
connective tissue partitions. In these projections . . . are found giant cell-like
large nucleated elements appearing singly or collected in nodules . . ."
With the coming of the 20th century, many different etiologic theories began to
appear in rapid succession." Various organisms were reported as etiologic organisms
because they had been isolated from a fair number of rheumatic fever patients. In no
instance, however, were Koch's postulates fulfilled with any of the various organisms
reported in the literature. Poynton and Paine isolated a strain of streptococcus viridans
which met an unhappy fate when it was blown up by German bombing in World
War I . Birkhaug recovered a hemolytic streptococcus. Small reported an organism
he termed streptococcus cardioarthriditis in 1928. Swift suggested the role of hypersensitivity in the production of the rheumatic state and this was soon supported
by Faber and Zinsser. Schlesinger, Sabin and others in the early 1930's demonstrated
that certain particles could be agglutinated by the sera of rheumatic fever patients and
felt that was supporting evidence for a viral etiology of the disease. In 1935 Rinehart
suggested the role of Vitamin C in the production of acute rheumatic fever. Certainly
an important contribution to our knowledge of the rheumatic state was made by
Coburn^" who published his study on the factor of infection in the rheumatic state
in 1931. Like others before him, he emphasized the variability of the disease. It is
interesting to those of us who are Pediatricians to note his description of the pulmonary
hyaline membrane at autopsy which we have come to think of as an exclusively
primary neonatal phenomenon, which it clearly is not. Coburn's major contribution
to our knowledge of the rheumatic state consisted of transporting a group of known
rheumatic fever patients from New York City, where the streptococcus was frequent,
to Puerto Rico, where the streptococcus was infrequent, for a period of 6 months.
In the relatively streptococcus-free atmosphere of Puerto Rico, these children experienced a gratifying regression of their rheumatic activity and a large proportion
returned to a state of physical health. However, when these children were returned to
New York City, a significant proportion experienced a recrudescence of rheumatic
activity. Coburn also carried out some interesting skin tests with bacterial nucleoproteins from various organisms, not all of which were streptococci. In some individuals
these skin tests produced interesting and rather startling results. Unfortunately the
results were not consistent regarding the streptococcus in these rheumatic susceptible
individuals. Certain rather disturbing reactions were seen—among them; the development
of generalized erythema marginatum, the development of rather extensive purpuric
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reactions, the appearance of rather deep sloughs and the appearance of nodular
erythema. Coburn felt four factors were involved in the production of rheumatic
fever symptomatology which he stated as follows; inherited susceptibility, age, environment and infection. It was concluded that rheumatic fever represented a special
tissue response to upper respiratory disease and that the streptococcus was an important
contributory factor.
No historical consideration of the rheumatic state would be complete without an
account of the curious and interesting history of the use of salicylates in this disease.
We recaU that in 1805 John Haygarth found Peruvian Bark excellent for the symptomatic treatment of the condition. In 1827 Leroux isolated the glycoside salicin from
Willow Bark. In 1838 Leroux obtained his salicin from the ordinary white willow
(Sahx alba) found in Europe. Piria isolated salicylic acid in 1838. He hydrolyzed
salicin which yielded glucose plus salicylic acid. Not much was done in an investigative
way until Thomas MacLagen" in 1874 observed that rheumatic fever was "apt to
occur in low-lying, damp localities . . . and was of miasmic origin", MacLagen felt
that the disease was allied to, but distinct from malaria. He reasoned that since
Cinchona bark was of value in malaria and was an extract of a bark indigenous to the
area in which malaria occurred, it was therefore only logical to seek a bark from
the native areas where rheumatic fever occurred to find a drug suitable for the
treatment of rheumatic fever. Hence, the bark of the willow, and its extract salicin,
should logically be used in the management of acute rheumatic fever. These observations were published in Lancet in 1876 and the suggestion was immediately accepted
by the medical profession and so salicylates have continued to be used to the present
day for the treatment of rheumatic symptomatology.
Interestingly enough, however, the train of thought noted above is not the only
one which led to the development of the very useful drug we know today as aspirin.''
In 1865, Joseph Lister conceived his idea of antisepsis through the use of a carbolic
acid spray and this work was published in Lancet in 1867. It was followed by the
attempt in 1874 of Herman Kolbe, a professor of chemistry in Leipzig, to produce
salicylic acid for use as an antibacterial agent with the idea in mind that it was a
phenol derivative which could be given by mouth. A little clinical experience soon
showed that salicylic acid produced only symptomatic relief and its antipyretic and
analgesic properties became well defined. Franz Strieker in Berlin found salicylates
were effective in the treatment of rheumatic fever, rheumatoid arthritis, neuritis,
neuralgia and headache, thereby antedating our current television advertisements by
some 85 years. Clinicians of the time found the gastro-intestinal side effects of salicyHc
acid and sodium salicylates were quite troublesome. This undesirable side effect of
the drugs stimulated a Bayer chemist, Felix Hoffman, whose father had rheumatoid
arthritis, to search out acetyl salicylic acid which he found about 1880. Actually this
compound had been synthesized in 1853 by Charles Von Gerhardt and nothing further
had been done with the material. It remained for almost thirty years a laboratory
curiosity. At Hoffman's suggestion, clinical trails of acetyl salicylic acid were conducted
by Heinrich Dresser, Bayer's pharmaceutical research chief, who found it useful
clinically. It was he who termed the material aspirin since natural salicylic acid came
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from plants of the spiria family and because it was also known as spiric acid, the
acetyl derivative might logically be called aspirin and so we have the name which
persisits today. In reviewing the literature of the time, one can infer, I think, that
clinicians of the period not infrequently encountered salicylism in patients under
treatment. Some of us may recall such patients in our own practices. Cheadle, in
his memorable monograph, suggests the advantages of the administration of alkalis
to patients who are receiving salicin. Today we are biochemically aware of the
ability of alkali to enhance the renal excretion of salicylates.
The commercial aspects of acetyl salicylic acid are not without interest. Quite
naturally, the Bayer Company took full patent advantage of the work of Hoffman,
Von Gerhardt and Heinrich in producing aspirin as a clinically useful drug. The
firm held exclusive rights for the commercial production of the material until the
expiration of the American patents in 1917. Anticipating this, the Monsanto Chemical
Company sent Dr. Gaston Dubois to Switzerland where he purchased rights to a
process for the cheap and efficient commercial production of the compound and with
the expiration of Bayer's American patents, Monsanto immediately went into production. Extensive litigation followed which ended in the year 1919 with the Bayer
Chemical Company losing the judgment. In that year, the Monsanto Chemical Company
produced 480,874 pounds of acetyl salicylic acid. By 1956 the Monsanto Chemical
Company had produced its 100th million pound of acetyl salicylic acid and an excellent
history of the drug was given by Dr. Carroll Hochwalt of the Monsanto Company
in the fall of 1956 at a Symposium on Aspirin Research. This address is printed in
the Journal of Pediatrics of the year 1957 and is well worth reading in its entirety.
With a review of the fascinating history of that most useful drug, aspirin, we
shall conclude consideration of the history of the development of our concept of the
rheumatic state. Many of those present this evening are more intimately familiar
with the details of the development of the potent steroid hormones than is the
speaker. In a sense, steroids are still in the process of making medical history. While
we know they are effective in ablating rheumatic symptomatology, we do not have
sufficient experience with them nor have we observed patients so treated for a sufficient
period of time to determine their ultimate long term effect on the rheumatic individual.
Moreover, after eleven years we are still not fully acquainted with their widespread
and subtle metabohc effects. Then too, the drug houses continue to add confusion
by producing synthetic steroids at an alarmingly rapid rate, the actions of which have
never been previously inflicted on the human organism. Possibly in twenty years
another T. Duckett Jones will appear to assay adequately that which we do today.
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